ambamustine has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekesi, JG; Yagi, MJ | 1 |
| Bekesi, JG; Holland, JF; Yagi, MJ; Zanjani, M | 1 |
| Bekesi, JG; Chin, SE; Scanlon, KJ; Yagi, MJ | 1 |
3 other study(ies) available for ambamustine and Malignant Melanoma
| Article | Year |
|---|---|
Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Leukemia L1210; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Nitrogen Mustard Compounds | 1983 |
Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
Topics: Animals; Cell Survival; Cells, Cultured; Female; Leukemia L1210; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitrogen Mustard Compounds | 1984 |
Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
Topics: Amino Acids; Animals; Antineoplastic Agents; Biological Transport; Mammary Neoplasms, Experimental; Melanoma; Nitrogen Mustard Compounds; Receptors, Amino Acid; Receptors, Cell Surface; Tumor Cells, Cultured | 1988 |